Gliosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 3%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 43%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (55)

clinicaltrialsPublishedShowing 51–100 of 123 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01454596	CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII	completed	Phase 1 / Phase 2	18	National Cancer Institute (NCI)NIH	1	Aug 21, 2019	clinicaltrials
NCT01514201	Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas	completed	Phase 1 / Phase 2	66	National Cancer Institute (NCI)NIH	1	Aug 13, 2019